For Women With Heavily-Treated Triple-Negative or HR+, HER2- Metastatic Breast Cancer, Padvec Shows Some Anti-Tumor Activity

For Women With Heavily-Treated Triple-Negative or HR+, HER2- Metastatic Breast Cancer, Padvec Shows Some Anti-Tumor Activity

NOW
PLAYING
The Latest in Managing Anemia for Patients With Myelodysplastic Syndrome
NOW
PLAYING
Rytelo Gains FDA Approval for Lower-Risk Myelodysplastic Syndrome: Reducing Need For Blood Transfusions & Improving Quality of Life
NOW
PLAYING
Imfinzi Improves Overall & Progression-Free Survival for Patients With Limited-Stage Small Cell Lung Cancer
NOW
PLAYING
Study: Physicians Should Prioritize Weight Management in Breast Cancer Care to Boost Survival Rates
NOW
PLAYING
Criteria and Considerations for Using Newly FDA-Approved Lifileucel in Advanced Melanoma
NOW
PLAYING
Physicians Advised to Consider Rybrevant for EGFR Mutation-Positive NSCLC, Following FDA Approval

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... breast cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider